bFGF对乳腺癌细胞系MCF-7细胞增殖与凋亡的影响

目的观察碱性成纤维细胞生长因子（bFGF）对体外培养人乳腺癌MCF-7细胞增殖和凋亡的影响,初步探讨bFGF作用机制。方法在饥饿培养的MCF-7细胞中加入bFGF和PD98059处理,以MTT法、吖啶橙染色及流式细胞术观察细胞生长与凋亡情况;并用Western blot检测caspase-3蛋白含量。结果对照组细胞形态发生改变：核质固缩、有凋亡小体形成;细胞凋亡率较高;Western blot分析表明,caspase-3蛋白明显表达。bFGF处理后,细胞变饱满,凋亡现象减少;细胞增殖比明显增加;与对照组相比凋亡细胞比例下降,并诱导细胞进入S期;随着bFGF浓度增加,caspase-3蛋白表达水平降低,在一定范围内呈剂量依赖性。加入PD98059可抑制bFGF的这些作用。结论bFGF可以促进细胞增殖,加速人乳腺癌细胞系MCF-7细胞的细胞周期进程,抵抗无血清饥饿诱导的凋亡,其作用部分可能是通过Ras-Raf-ERK1/2途径介导的。     

槟榔碱对人乳腺癌MCF-7细胞增殖和凋亡的影响

目的：观察槟榔碱对人乳腺癌细胞（MCF-7）增殖和凋亡的影响,并探讨其机制。方法：采用四甲基偶氮唑盐（MTT）法检测不同浓度（0、10、30、50、100、300、500μmol/L）槟榔碱对MCF-7细胞增殖的影响,Hoechst 33342染色和流式细胞术检测细胞凋亡,Western blot法检测Bax,Bcl-2和P53蛋白表达。结果：低浓度（0、10、30、50μmol/L）槟榔碱不影响细胞的增殖和凋亡;而高浓度（100、300、500 μmol/L）槟榔碱呈浓度依赖性抑制MCF-7细胞增殖、诱导MCF-7细胞凋亡、提高P53和Bax蛋白表达、降低Bcl-2蛋白表达。结论：高浓度槟榔碱抑制MCF-7细胞增殖、诱导凋亡,其机制可能与提高P53和Bax蛋白表达,降低Bcl-2蛋白表达有关。     

白藜芦醇对乳腺癌细胞MCF-7增殖的影响

目的：研究白藜芦醇体外活性,确定它的植物雌激素作用。方法：采用MTT法观察不同浓度白藜芦醇对MCF-7细胞增殖作用的影响。采用DNA ladder法和荧光显微镜观察高浓度白藜芦醇对细胞的影响。免疫组化法观察低浓度白藜芦醇对核增殖抗原PCNA表达的影响。结果：MTT结果显示白藜芦醇高浓度抑制MCF-7细胞增殖,IC50为8.70×10-5mol/L;低浓度（10-7~10-6mol/L）则对细胞有促增殖作用,最高促增殖浓度为1.0×10-7mol/L。DNA ladder和荧光显微镜可观察到高浓度白藜芦醇作用后细胞典型的凋亡形态。免疫组化结果显示低浓度白藜芦醇作用后,细胞核内PCNA表达明显增加（P〈0.05）。结论：高、低浓度的白藜芦醇对MCF-7细胞分别表现为诱导凋亡和促增殖作用,呈现出植物雌激素对MCF-7细胞典型的双向调节作用。     

白藜芦醇对乳腺癌细胞MCF-7 增殖的影响

目的:研究白藜芦醇体外活性,确定它的植物雌激素作用。方法:采用MTT法观察不同浓度白藜芦醇对MCF-7细胞增殖作用的影响。采用DNA ladder法和荧光显微镜观察高浓度白藜芦醇对细胞的影响。免疫组化法观察低浓度白藜芦醇对核增殖抗原PCNA表达的影响。结果:MTT结果显示白藜芦醇高浓度抑制MCF-7细胞增殖,IC50为8.70×10-5mol/L;低浓度(10-7~10-6mol/L)则对细胞有促增殖作用,最高促增殖浓度为1.0×10-7mol/L。DNA ladder和荧光显微镜可观察到高浓度白藜芦醇作用后细胞典型的凋亡形态。免疫组化结果显示低浓度白藜芦醇作用后,细胞核内PCNA表达明显增加(P<0.05)。结论:高、低浓度的白藜芦醇对MCF-7细胞分别表现为诱导凋亡和促增殖作用,呈现出植物雌激素对MCF-7细胞典型的双向调节作用。     

细胞骨架与细胞凋亡及细胞内信息通路的关系

细胞骨架是细胞内最高级的组织者和管理者,根据功能将各种细胞器相对集中在细胞内的某一区域,并通过多种信息通路相互联系,使细胞内部形成一个"城市",各服务器进行有序的工作.此时,一些信号通过一定的作用模式,如诱导因素通过第二信使系统将信号传入细胞内,最终汇集到公共通道,改变细胞基因表达的类型、水平及其时序性,最后导致生理反应或程序性细胞死亡中特征性生物化学改变,但这种细胞内外的信号-受体-胞内传递-基因转录-应答反应的传递方式并不是一条龙式的单一联系,各条途径之间存在着多方式、多水平的横向联系和交互作用,形成信号传递网络.基于细胞骨架在细胞内的特殊地位和功能,可以相信,通过对细胞骨架及其与细胞内某些分子关系的研究,将有助于深入了解细胞内的信息传递规律,为揭示细胞内分子在体现细胞生物学特性方面的有机联系提供证据.     

miR-449a对人乳腺癌细胞MCF-7增殖及迁移能力的影响

目的：通过敲低微小RNA （microRNA,miRNA）-449a的方法研究miR-449a对人乳腺癌细胞MCF-7的增殖和迁移能力的影响。方法：采用miRNA芯片在乳腺癌细胞MCF-7和人正常乳腺细胞MCF-10A筛选具有表达差异的miRNA;化学合成法制备miR-449a的抑制剂（inhibitor）,转染后经real-time PCR验证表达的变化;细胞增殖CCK-8实验对转染后细胞增殖能力进行检测;划痕实验检测细胞转移能力,transwell小室实验检测细胞侵袭的改变;蛋白免疫印迹法（Western blot）实验对MCF-7细胞增殖和迁移相关的β-catenin和E-cadherin蛋白进行检测;通过生物信息学软件预测miR-449a潜在靶基因为Notch 1,荧光素酶实验检测Notch 1是miR-449a的靶基因。结果：分别收集MCF-7和MCF-10A细胞,芯片结果显示miR-449a在MCF-7细胞的表达水平显著高于MCF-10A;本研究将细胞分为未处理组（Mock组）,阴性对照组（negative control组,NC组）和处理组,通过收集不同组MCF-7细胞进行试验,CCK-8结果显示miR-449a下调后MCF-7细胞增殖能力显著降低;划痕实验结果显示miR-449a表达降低导致MCF-7细胞转移能力降低;transwell实验结果显示MCF-7细胞侵袭受到抑制;Western blot结果发现miR-449a敲低后β-catenin表达降低,E-cadherin表达增加;荧光素酶试验结果显示,miR-449a能够显著降低Notch 1-3'-UTR质粒的荧光素活性（P<0.01）。结论：在乳腺癌细胞MCF-7中敲低miR-449a能够显著抑制癌细胞增殖和迁移,而这一变化可能通过降低Notch 1蛋白表达实现的。     

重组人S100A6促进人乳腺癌细胞MCF-7的增殖和迁移侵袭并抑制其凋亡

该研究旨在探讨重组人S100A6蛋白对乳腺癌细胞株MCF-7的增殖、凋亡、迁移及侵袭能力的影响。利用原核表达制备重组人S100A6蛋白(GST-hS100A6),SDS-PAGE显示其大小为36 kDa,Western blot显示其可以被S100A6抗体特异识别,BCA法测定1 L菌液共收获约16.7 mg蛋白;将其作用于人乳腺癌细胞MCF-7,MTT显示细胞培养48 h时,浓度为100μg/mL和300μg/mL的GST-hS100A6组的D_(492)值较GST组增加29.1%和84.6%(P<0.05),提示S100A6促进MCF-7细胞增殖;平板克隆形成实验显示GST-hS100A6组的克隆形成率较GST组高38.7%(P<0.05),提示S100A6促进MCF-7的克隆形成;Hoechst染色显示GST-hS100A6组在24 h时细胞凋亡率较GST组减少67.8%(P<0.05),48 h时细胞凋亡率较GST组减少58.4%(P<0.05),提示S100A6抑制MCF-7细胞凋亡;划痕实验显示在24 h时GST-hS100A6组的划痕愈合率为GST组的2.2倍(P<0.05),提示S100A6促...     

Caveolin-1对乳腺癌细胞系MCF-7增殖和存活的影响

该文研究窖蛋白(Caveolin-1)对乳腺癌细胞系MCF-7细胞增殖与存活的影响。运用蛋白质印迹方法(Western blot)检测发现,caveolin-1在5株不同细胞系均只有低表达。运用电穿孔转染方法在乳腺癌细胞系中高表达Caveolin-1,运用Western blot检测转染后Caveolin-1表达情况发现,转染后细胞内Caveolin-1表达上升,并具有生物活性。运用单核细胞直接细胞毒性测定法(MTT)检测发现,转染后乳腺癌细胞系MCF-7增殖速度降低。运用Western blot方法和免疫荧光(immunofluorescence)方法检测转染后细胞凋亡途径的变化,磷酸化的P38蛋白含量上升,Bax表达量明显上升。据此推测Caveolin-1抑制MCF-7细胞的增殖和存活,并诱导基于Bax途径的细胞凋亡。     

色胺酮对乳腺癌MCF-7细胞凋亡的诱导作用

目的:探讨色胺酮(Tryptanthrin,Try)对人乳腺癌MCF-7细胞增殖和凋亡的影响。方法:利用MTT方法检测Try(1.56-100μmol/L)对细胞增殖的影响;透射电镜观察细胞的形态学改变;流式细胞术检测细胞周期、凋亡情况及线粒体跨膜电位等指标。结果:MTT结果显示,Try在12.5-100μmol/L浓度范围内能明显抑制MCF-7细胞的增殖,并具有时间和浓度依赖性;透射电镜下可见Try作用48h后,MCF-7细胞有典型的凋亡样改变。Annexin V-FITC与PI双染,流式细胞仪检测结果显示:50、100μmol/LTry作用后,细胞的凋亡情况明显,与对照组相比差异显著;且影响了MCF-7的细胞周期分布,将细胞阻滞于G1期,抑制其DNA的合成;并导致细胞线粒体跨膜电位下降。结论:色胺酮能明显抑制MCF-7细胞增殖并具有诱导细胞发生凋亡的作用。     

灰树花多糖对乳腺癌细胞MCF-7的凋亡作用

采用MTT法测定不同给药浓度的灰树花多糖(PGF) (1、10、20、50、100和200 μg/mL)在24、48和72 h对乳腺癌细胞(MCF-7)增殖的抑制率,并采用Hoechst染色与流式细胞技术观察20、50和100 μg/mL PGF给药24 h后MCF-7的凋亡情况,同时采用Western blotting对20、50、100 μg/mL PGF给药24 h后MCF-7细胞中Bax、Bcl-2、Pro-Caspase-3以及Cleaved Caspase-3的蛋白表达水平进行检测。研究发现PGF给药24、48和72 h后对MCF-7的增殖均有显著的抑制作用。随着PGF给药浓度增加,MCF-7细胞核裂解增多,细胞凋亡数量增多。PGF 20、50和100 μg/mL给药对MCF-7细胞Bax、Bcl-2、Pro-Caspase-3以及Cleaved Caspase-3的蛋白表达水平可见显著性差异。     

Integrin and cytoskeleton behaviour in human neuroblastoma cells during hyperthermia-related apoptosis

Hyperthermia induces several cellular responses leading to morphological changes, cell detachment and death. Loss of integrins from the cell surface after acute heat-treatment may block several physiological signalling pathways, but whether the assembly network between integrin and cytoskeletal actin is perturbed during hyperthermic treatment is unknown. In this study we tested this hypothesis by evaluating cell morphology, protein cytoskeletal profile and integrin CD11a content in both adherent and floating SK-N-MC human neuroblastoma cells. Morphological and cytometric analyses confirmed that hyperthermia is an effective apoptotic trigger, revealing the typical chromatin margination, cell shape changes and 7-AAD incorporation. After hyperthermia, cytoskeletal proteins showed an increase of high-molecular-weight aggregates and a significant decrease of both actin and CD11a content with respect to control cells. The integrin CD11a and membrane-bound actin alterations found in detached floating neuroblastoma cells recovered after heat-shock may cause the cytoskeletal abnormalities related to the observed surface cell rounding/blebbing and anoikis, early events of hyperthermia-induced programmed cell death.     

Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling

Abstract

In this study, novel thiosemicarbazides and 1,3,4-oxadiazoles were synthesized and evaluated for their anticancer effects on human MCF-7 breast cancer cell lines. Among the synthesized derivatives studied, compound 2-(3-(4-chlorophenyl)-3-hydroxybutanoyl)-N-phenylhydrazinecarbothioamide 4c showed the highest cytotoxicity against MCF-7 breast cancer cells as it reduced cell viability to approximately 15% compared to approximately 25% in normal breast epithelial cells. Therefore, we focused on 4c for further investigations. Our data showed that 4c induced apoptosis in MCF-7 cells which was further confirmed by TUNEL assay. Western blotting analysis showed that compound 4c up-regulated the pro-survival proteins Bax, Bad and ERK1/2, while it down-regulated anti-apoptotic proteins Bcl-2, Akt and STAT-3. Additionally, 4c induced phosphorylation of SAPK/JNK in MCF-7 cells. Pretreatment of MCF-7 cells with 10?µM of JNK inhibitor significantly reduced 4c-induced apoptosis. Molecular docking results suggested that compound 4c showed a binding pattern close to the pattern observed in the structure of the lead fragment bound to JNK1. Collectively, the data of current study suggested that the thiosemicarbazide 4c might trigger apoptosis in human MCF-7 cells by targeting JNK signaling.     

Visfatin stimulates proliferation of MCF-7 human breast cancer cells

Obesity, a condition characterized by increased fat content and altered secretion of adipokines, is a risk factor for postmenopausal breast cancer. Visfatin has recently been established as a novel adipokine that is highly enriched in visceral fat. Here we report that visfatin regulated proliferation of MCF-7 human breast cancer cells. Exogenous administration of recombinant visfatin increased cell proliferation and DNA synthesis rate in MCF-7 cells. Furthermore, visfatin activated G1-S phase cell cycle progression by upregulation of cyclin D1 and cdk2 expression. Visfatin also increased the expression of matrix metalloproteinases 2, matrix metalloproteinases 9, and vascular endothelial growth factor genes, suggesting that it may function in metastasis and angiogenesis of breast cancer. Taken together, these findings suggest that visfatin plays an important role in breast cancer progression.     

Fatty acid modulation of MCF-7 human breast cancer cell proliferation,apoptosis and differentiation

Epidemiological studies suggest that dietary polyunsaturated fatty acids (PUFA) may influence breast cancer progression and prognosis. In order to study potential mechanisms of action of fatty acid modulation of tumor growth, we studied, in vitro, the influence of n-3 and n-6 fatty acids on proliferation, cell cycle, differentiation and apoptosis of MCF-7 human breast cancer cells. Both eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) inhibited the MCF-7 cell growth by 30% and 54%, respectively, while linoleic acid (LA) had no effect and arachidonic acid (AA) inhibited the cell growth by 30% (p < 0.05). The addition of vitamin E (10uM) to cancer cells slightly restored cell growth. The incubation of MCF-7 cells with PUFAs did not alter the cell cycle parameters or induce cell apoptosis. However, the growth inhibitory effects of EPA, DHA and AA were associated with cell differentiation as indicated by positive Oil-Red-O staining of the cells. Lipid droplet accumulation was increased by 65%, 30% and 15% in the presence of DHA, EPA and AA, respectively; (p < 0.05). These observations suggest that fatty acids may influence cellular processes at a molecular level, capable of modulating breast cancer cell growth.     

Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells

Recently, salidroside (p-hydroxyphenethyl-β-d-glucoside) has been identified as one of the most potent compounds isolated from plants of the Rhodiola genus used widely in traditional Chinese medicine, but pharmacokinetic data on the compound are unavailable. We were the first to report the cytotoxic effects of salidroside on cancer cell lines derived from different tissues, and we found that human breast cancer MDA-MB-231 cells (estrogen receptor negative) were sensitive to the inhibitory action of low-concentration salidroside. To further investigate the cytotoxic effects of salidroside on breast cancer cells and reveal possible ER-related differences in response to salidroside, we used MDA-MB-231 cells and MCF-7 cells (estrogen receptor-positive) as models to study possible molecular mechanisms; we evaluated the effects of salidroside on cell growth characteristics, such as proliferation, cell cycle duration, and apoptosis, and on the expression of apoptosis-related molecules. Our results demonstrated for the first time that salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells and may be a promising candidate for breast cancer treatment.     

The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells

Doxorubicin (Adriamycin) is the most active drug in the treatment of breast cancer. The aim of this study was to investigate the interaction of doxorubicin and retinoids in the inhibition of proliferation of hormone sensitive (ER+) human breast cancer cell line MCF-7 and to find out whether this combination can result in the enhancement of its therapeutic effect. As a comparison we also used estradiol and tamoxifen. We also made an attempt to elucidate the effect of these compounds on the stimulation of the apoptotic pathway in breast cancer cells. Cell proliferation in a 24-hour culture was assessed by [3H] thymidine incorporation into cancer cells and by immunocytochemical analysis of cellular cycle-related PCNA and Ki-67 antigens expression, after the incubation of the cell culture with 10, 20 and 50 nM doxorubicin (DOX), 2 nM estradiol (E2), 10 microM tamoxifen (TAM) and 1 nM, 0.01, 0.1, 1 and 10 microM of all-trans retinoid acid (ATRA). The assessment of cell viability and analysis of apoptotic and necrotic cells were performed after the 72-hour incubation of the culture with the examined substances and following apoptosis induction using acridine orange and ethidine bromide. Of the doxorubicin concentrations used in the study, 20 nM inhibited thymidine incorporation to 84.83 +/- 10.00% (control=100%). In the same culture conditions, 2 nM E2 stimulated cancer cells to 157.09 +/- 8.84%. Concentrations of 10 microM TAM and 10 microM ATRA inhibited the proliferation to 63.16 +/- 7.85% and 52.19 +/- 3.21%, respectively. A statistically significant reduction of these values was observed when 20 nM DOX was added to medium with E2 - 39.24 +/- 7.6%, TAM - 48.34 +/- 2.05% and ATRA - 21.98 +/- 1.69%, respectively; the percentage of PCNA- and Ki-67-positive cells was also reduced. Despite high antiproliferative efficacy of 20 nM DOX and 10 microM ATRA combination, the percentage of apoptotic cells was only 25 +/- 0.81%, being similar to that obtained in the culture with 20 nM DOX. The concentrations of 10, 20 and 50 nM DOX that were used to inhibit the proliferation of MCF-7 cell line were not particulary effective. The inhibitory effect was obtained when 20 nM of DOX and E2, TAM or ATRA were used simultaneously. The use of E2 caused a two-fold decrease in the percentage of proliferating cells. It was also shown that the effectiveness of DOX in combination with ATRA is significantly higher than that of DOX combined with TAM, which might suggest a valuable approach to the treatment of breast cancer.